Table 4.

Outcomes for Men Aged 40 to 49 with Abnormal PSA (> 1.5 ng/ml) in the Pre- and Post-implementation Periods

Category	Pre-implementation		Post-implementation
	N	%	N	%
Total number of men with abnormal PSA	366	2.7*	583	4.9*
Age 40–44	83	22.7	137	23.5
Age 45–49†	283	77.3	427	73.2
PSA repeated by PCP	23	6.3	166	28.5
PCP-referred patient	38	10.4	323	55.4
Referral completed	22	6.0	205	35.2
Men with prostate biopsy	12	3.3	33	5.7
Men with prostate cancer on biopsy	3	0.8	11	1.9

*Percent of total men aged 40 to 49 seen in the respective period

†Age 45–49 in the post-implementation does not also include 3.3% aged 50–55

PSA, prostate-specific antigen; PCP, primary care provider